Employers may be starting to get the hang of specialty pharmacy. In the latest survey from the Midwest Business Group on Health, 49% of responding companies say they have an above average understanding of the benefit; in 2011, 78% claimed a low to moderate understanding.
MBGH, with guidance from Randy Vogenbuerg, PhD questioned approximately 70 employers with populations between 1,001 and 15,000 about knowledge and benefit design regarding specialty pharmacy drugs and biologic products used to treat conditions such as multiple sclerosis and arthritis. These drugs present unique logistical issues, as well as significant cost challenges.
